Showing results (141-150 of 173) with videos related to
Sort By:
Pageof 18
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) StudyElena Gkrouzman, Rohan Willis, Danieli Andrade, et al.The Journal of Clinical Investigation|April 22, 2025
Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responsesMir J Howlader, William G Ambler, Madhavi Latha S Chalasani, et al.Frontiers in Immunology|November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.Thrombosis Research|January 28, 2019
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysisSavino Sciascia, Rohan Willis, Vittorio Pengo, et al.Frontiers in Immunology|May 18, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.Frontiers in Immunology|April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.Frontiers in Immunology|June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.Arthritis Care & Research|April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and RepositoryOzan Unlu, Doruk Erkan, Medha Barbhaiya, et al.Rheumatology (Oxford, England)|November 25, 2010
Pregnancy and reproduction in autoimmune rheumatic diseasesMonika Ostensen, Antonio Brucato, Howard Carp, et al.Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.Pageof 18